| Literature DB >> 30963178 |
Meredith L McMorrow1,2,3, Stefano Tempia1,2,4,5, Sibongile Walaza4,6, Florette K Treurnicht4,7, Jocelyn Moyes4,6, Adam L Cohen1,2,3,8, Marthi Pretorius4,9, Orienka Hellferscee4,7, Nicole Wolter4,7, Anne von Gottberg4,7, Arthemon Nguweneza4, Johanna M McAnerney4, Fathima Naby10, Omphile Mekgoe11, Marietjie Venter12, Shabir A Madhi13,14, Cheryl Cohen4,6.
Abstract
From 2011 through 2016, we conducted surveillance for severe respiratory illness in infants. Human immunodeficiency virus exposure significantly increased the risk of respiratory syncytial virus (RSV)-associated hospitalization in infants aged <5 months. More than 60% of RSV-associated hospitalizations occurred in the first 4 months of life and may be preventable through maternal vaccination or birth-dose monoclonal antibody. Published by Oxford University Press for the Infectious Diseases Society of America 2019.Entities:
Keywords: South Africa; human immunodeficiency virus; incidence; respiratory syncytial virus
Mesh:
Year: 2019 PMID: 30963178 PMCID: PMC6934254 DOI: 10.1093/cid/ciz288
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079